3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Oxidized LDL is stable in human serum under extended thawed-state conditions ranging from −20 °C to room temperature

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Highlights

          • Oxidized LDL in serum is stable for extended periods at 23 °C, 4 °C, and −20 °C.

          • A marker of thawed-state exposure, ΔS-Cys-Albumin, served as a positive control.

          Abstract

          Introduction

          Oxidized LDL (oxLDL) is formed by the spontaneous reaction between aldehyde byproducts of lipid peroxidation and lysine residues of apolipoprotein B within LDL. Clinically, oxLDL is used as a marker of coronary artery disease and predictor of metabolic syndrome risk. Despite its popularity as a clinical marker, no systematic studies of oxLDL stability, in which serum or plasma has been pre-analytically exposed to an array of different time and temperature conditions, have been carried out.

          Objective

          To systematically evaluate the stability of oxLDL in human serum samples exposed to thawed conditions (> −30 °C) for varying periods of time while monitoring a second protein/small molecule redox system as a positive control for non-enzymatic biomolecular activity.

          Methods

          OxLDL was measured in serum samples, from 24 different humans, that had been pre-exposed to three different time courses at 23 °C, 4 °C and −20 °C using ELISA kits from Mercodia that employ the 4E6 mouse monoclonal antibody. A liquid chromatography/mass spectrometry-based marker of serum exposure to thawed conditions known as ΔS-Cys-Albumin was employed as a positive control.

          Results

          OxLDL was stable in serum exposed to 23 °C for up to 48 h, 4 °C for 21 days, or −20 °C for 65 days. ΔS-Cys-Albumin changed dramatically during these time courses (p < 0.001).

          Conclusions

          OxLDL is remarkably stable ex vivo in human serum samples exposed to thawed conditions.

          Related collections

          Most cited references38

          • Record: found
          • Abstract: found
          • Article: not found

          Atherosclerosis: Basic Mechanisms

          Circulation, 91(9), 2488-2496
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.

            Lp(a) lipoprotein binds proinflammatory oxidized phospholipids. We investigated whether levels of oxidized low-density lipoprotein (LDL) measured with use of monoclonal antibody E06 reflect the presence and extent of obstructive coronary artery disease, defined as a stenosis of more than 50 percent of the luminal diameter. Levels of oxidized LDL and Lp(a) lipoprotein were measured in a total of 504 patients immediately before coronary angiography. Levels of oxidized LDL are reported as the oxidized phospholipid content per particle of apolipoprotein B-100 (oxidized phospholipid:apo B-100 ratio). Measurements of the oxidized phospholipid:apo B-100 ratio and Lp(a) lipoprotein levels were skewed toward lower values, and the values for the oxidized phospholipid:apo B-100 ratio correlated strongly with those for Lp(a) lipoprotein (r=0.83, P<0.001). In the entire cohort, the oxidized phospholipid:apo B-100 ratio and Lp(a) lipoprotein levels showed a strong and graded association with the presence and extent of coronary artery disease (i.e., the number of vessels with a stenosis of more than 50 percent of the luminal diameter) (P<0.001). Among patients 60 years of age or younger, those in the highest quartiles for the oxidized phospholipid:apo B-100 ratio and Lp(a) lipoprotein levels had odds ratios for coronary artery disease of 3.12 (P<0.001) and 3.64 (P<0.001), respectively, as compared with patients in the lowest quartile. The combined effect of hypercholesterolemia and being in the highest quartiles of the oxidized phospholipid:apo B-100 ratio (odds ratio, 16.8; P<0.001) and Lp(a) lipoprotein levels (odds ratio, 14.2; P<0.001) significantly increased the probability of coronary artery disease among patients 60 years of age or younger. In the entire study group, the association of the oxidized phospholipid:apo B-100 ratio with obstructive coronary artery disease was independent of all clinical and lipid measures except one, Lp(a) lipoprotein. However, among patients 60 years of age or younger, the oxidized phospholipid:apo B-100 ratio remained an independent predictor of coronary artery disease. Circulating levels of oxidized LDL are strongly associated with angiographically documented coronary artery disease, particularly in patients 60 years of age or younger. These data suggest that the atherogenicity of Lp(a) lipoprotein may be mediated in part by associated proinflammatory oxidized phospholipids. Copyright 2005 Massachusetts Medical Society.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Measurement and Clinical Significance of Lipid Peroxidation as a Biomarker of Oxidative Stress: Oxidative Stress in Diabetes, Atherosclerosis, and Chronic Inflammation

              Endothelial dysfunction is one of the initial steps in the pathogenesis of atherosclerosis and development of cardiovascular disease in patients with diabetes mellitus. Several risk factors are associated with endothelial dysfunction and atherosclerosis, such as hypertension, dyslipidaemia, inflammation, oxidative stress, and advanced glycation-end products. Among these risk factors, oxidative stress is the largest contributor to the formation of atherosclerotic plaques. Measurement of reactive oxygen species (ROS) is still difficult, and assays for the measurement of ROS have failed to show a consistent correlation between pathological states and oxidative stress. To solve this problem, this review summarizes the current knowledge on biomarkers of oxidative stress, especially lipid peroxidation, and discusses the roles of oxidative stress, as measured by indices of lipid peroxidation, in diabetes mellitus, atherosclerosis, and chronic inflammation.
                Bookmark

                Author and article information

                Contributors
                Journal
                J Mass Spectrom Adv Clin Lab
                J Mass Spectrom Adv Clin Lab
                Journal of Mass Spectrometry and Advances in the Clinical Lab
                Elsevier
                2667-1468
                2667-145X
                09 December 2022
                January 2023
                09 December 2022
                : 27
                : 18-23
                Affiliations
                [a ]School of Molecular Sciences, Arizona State University, Tempe, AZ 85287, United States
                [b ]The Biodesign Institute at Arizona State University, Tempe, AZ 85287, United States
                [c ]College of Health Solutions, Arizona State University, Phoenix, AZ 85004, United States
                Author notes
                [* ]Corresponding author at: The Biodesign Institute at Arizona State University, P.O. Box 876401, Tempe, AZ 85287, United States. chad.borges@ 123456asu.edu
                [1]

                These authors contributed equally to this work.

                Article
                S2667-145X(22)00043-8
                10.1016/j.jmsacl.2022.12.001
                9791165
                36578466
                048754c0-eab9-4036-b607-c5c1ee771468
                © 2022 THE AUTHORS

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                : 27 August 2022
                : 4 December 2022
                : 6 December 2022
                Categories
                Articles from the special issue on Biospecimen Pre-Analytics: Identifying and Controlling Ex Vivo Distortion of In Vivo Reality Edited by Chad Borges, Anne Bendt, Robert Gurke and Julijana Ivanisevic

                oxldl, oxidized low-density lipoprotein,cad, coronary artery disease,chd, coronary heart disease,oxidized ldl,serum,stability

                Comments

                Comment on this article